Exhibit 99.1

                                                                      GP42SN147L

EDITORIAL CONTACT:

Michele Drake
+1 650 752 5296
michele_drake@agilent.com

INVESTOR CONTACT:

Hilliard Terry
+1 650 752 5329
hilliard_terry@agilent.com

           Agilent Technologies Announces Closing of Private Offering
                  of 3% Senior Convertible Debentures Due 2021

         PALO ALTO, Calif., Nov. 27, 2001 -- Agilent Technologies Inc. (NYSE: A)
today announced the closing of a private offering of $1 billion aggregate
principal amount of its 3% Senior Convertible Debentures due 2021. The offering
was made only to qualified institutional buyers. Agilent intends to use the net
proceeds of the offering for working capital and general corporate purposes,
including funding potential acquisitions and restructuring costs.

         The underwriters have also elected to exercise their option to purchase
an additional $150,000,000 in aggregate principal amount of the 3% Senior
Convertible Debentures, which is expected to be settled in a separate closing on
Nov. 29, 2001.

         The debentures will be convertible into Agilent's common stock
initially at a conversion price of $32.22 per share. The initial conversion
price represents a 32% premium over the last reported sale price of Agilent's
common stock on Nov. 19, 2001, which was $24.41 per share.

         The debentures will be redeemable at the company's option beginning in
December 2004, and holders of the debentures will have the ability to require
Agilent to repurchase the debentures, in whole or in part, on specified dates in
2006, 2011 and 2016.

         The securities have not been registered under the Securities Act of
1933, as amended (the "Securities Act"), or any state securities laws, and
unless so registered, may not be offered or sold in the United States except
pursuant to an exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act and applicable state securities
laws.

         This press release does not constitute an offer to sell, or the
solicitation of an offer to buy, any security and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offering would be
unlawful.

         Cautionary Statement: Agilent's statements in this press release that
are not historical facts and that relate to future plans or events are
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements include
Agilent's intention to consummate the sale of the additional debentures and the
intended use of proceeds. The closing of the sale of the additional debentures
is subject to conditions, and there can be no assurance that Agilent will
complete the sale of the additional debentures. In addition, Agilent's business
is subject to the risks described in the Company's filings with the Securities
and Exchange Commission.

                                      # # #

                                       - 1 -